Conjunctival Lesions

Colleen Halfpenny


BASICS


DESCRIPTION


Benign conjunctival lesions are a group of tumors, including papilloma (Pap), Kaposi’s sarcoma (KS), limbal dermoid (LD), sarcoidosis (Sarc), and pyogenic granuloma (PG) with a low potential for malignant growth and a wide variety of etiologies and management considerations.


EPIDEMIOLOGY


Incidence


• Systemic KS: 4–14% in ocular adnexa (1)[C]


• Ocular KS: 7–18%


• Ocular Sarc: 7–19%


RISK FACTORS


• Pap: Mother with positive human papillomavirus (HPV) history, UV radiation


• KS: Immunocompromised states, including HIV/AIDS, chemotherapy, organ transplantation, elderly males


• LD: <18 years of age


• Sarc: African American race


• PG: transconjunctival surgical incisions (strabismus, retinal surgery), trauma (2)[B]


Genetics


Sarc: HLA-Bw15, HLA-B8, HLA-B13


PATHOPHYSIOLOGY


• Pap: HPV, a double-stranded DNA virus transmitted via direct contact, often through passage of infected birth canal leading to proliferation of fibrovascular connective tissue, acanthosis, and hyperkeratosis


• KS: Dysregulated inflammatory cytokine response due to human herpesvirus-8


• LD: Congenital choristomatous changes due to an unknown process; classified based upon the extent of anterior segment involvement


• Sarc: Inflammatory hyperactivity due to dysregulated cytokine responses following an antigenic stimulus


• PG: Proliferative fibrovascular and inflammatory response usually secondary to aberrant wound healing


ETIOLOGY


• Pap: HPV, most commonly benign types 6 and 11, rarely type 16 or 45


• KS: Human herpesvirus-8 (HHV-8) DNA or Kaposi’s sarcoma-associated herpesvirus (KSHV), implicated with patients who are HIV-negative and HIV-positive


• Sarc: Unknown etiology. Suggested causes: Environmental toxins, infectious agents, genetic transmission


• LD: Unknown


• PG: Usually due to prior inflammatory condition or status post trauma or surgery


COMMONLY ASSOCIATED CONDITIONS


• LD: Goldenhar’s syndrome


• Sarc: Mikulicz’s syndrome: Salivary and lacrimal gland enlargement with keratoconjunctivitis sicca


DIAGNOSIS


HISTORY


• Pap, KS, LD, Sarc, PG:


– often asymptomatic


– mass effect symptoms


– foreign body sensation


– itching


– tearing


– mucous


– ptosis


– photophobia


– blurry vision


– swelling


– trichiasis


– poor lid apposition


– cosmetic effects


• KS: Immune status


• Sarc: Lung and skin nodules, dyspnea, cough malaise, fatigue, lymphadenopathy


• LD: <18 years of age, enlarging since birth, especially after puberty


• PG: History of surgery, inflammatory condition


PHYSICAL EXAM


• Pap: Pedunculated or sessile, pink-red, fleshy, smooth often verrucous appearing on bulbar or palpebral conjunctiva. Viral usually multiple lesions in inferior fornix; single lesions may suggest nonviral etiology and may extend toward the limbus.


• KS: Flat or raised, reddish-purple, oval, nontender mass, or nodular, well-circumscribed lesion


• Sarc: Single or multiple, yellow or salmon colored nodules. Most commonly on palpebral conjunctiva of lower cul-de-sac or plica semilunaris


• LD: Yellowish-white oval-shaped, solid mass involving bulbar conjunctiva, typically near the inferotemporal corneoscleral limbus; may have fine hairs


• PG: well-vascularized, elevated, red-fleshy mass with fibrous stalk


• Secondary findings for all of the above include chemosis, mechanical ectropion, superficial punctuate keratopathy, and corneal dellen.


DIAGNOSTIC TESTS & INTERPRETATION


Lab


• KS:  HIV ELISA, HIV Western Blot, CD4


• Sarc: Angiotensin-converting enzyme, calcium, magnesium, phosphorous


Imaging


Sarc: Chest X-ray


Diagnostic Procedures/Other


• Slit lamp, dilated fundus examination, tonometry


• Pap, KS, Sarc, PG: incisional or excisional biopsy, if suspicious for malignancy


• LD: Depth of corneal involvement can be evaluated with ultrasound biomicroscopy (UBM). Examine patient for signs and symptoms of Goldenhar’s syndrome, including preauricular skin appendages, hearing loss, lid coloboma, and naso-oro-vertebral anomalies (4)[C].


Pathological Findings


• Pap: Multiple branching fronds with a fibrovascular core lined by thickened, acanthotic, squamous epithelium with or without koilocytosis


• KS: Thin, dilated, endothelial-lined vascular channels surrounded by spindle cells and inflammatory reaction


• LD: Conjunctival epithelium with epidermal appendages surrounding simple choristomatous tissue including hair follicles, sebaceous glands, muscle, adipose, teeth, bone, and cartilage


• Sarc: Noncaseating granulomas


• PG: Granulation tissue, chronic inflammation, small blood vessels


DIFFERENTIAL DIAGNOSIS


• Pap: Conjunctival intraepithelial neoplasia, squamous cell carcinoma, amelanotic melanoma, lymphoma


• KS: Subconjunctival hemorrhage, hemangiopericytoma, pyogenic granuloma, capillary and cavernous hemangioma, lymphoma, malignant melanoma, pingueculitis, bacillary angiomatosis


• Sarc: Chalazia, pyogenic granuloma, conjunctival intraepithelial neoplasia, mycobacterial infections, fungal infection, foreign body granuloma, papilloma


• DL: Pterygium, pinguecula, juvenile xanthogranuloma, staphyloma, foreign body reaction, sclerocornea


• PG: Foreign body granuloma, chalazion, sarcoidosis, papilloma, lymphoma


TREATMENT


MEDICATION


First Line


• Pap: Observation for spontaneous resolution


• LD: Topical lubrication, removal of irritating hairs


• KS: Highly active antiretroviral therapy (HAART) (1)[B]


• Sarc: Topical steroid


• PG: Observation for spontaneous resolution


Second Line


• Pap: Topical interferon-alpha-2b, mitomycin C, oral cimetidine (3)[C]


• KS: Local chemotherapy (vinblastine and vincristine), low dose radiotherapy, topical interferon-alpha, human choriogonadotropin


• PG: Low-dose plaque radiotherapy for recurrent PG (4)[C]


ADDITIONAL TREATMENT


Issues for Referral


LD: If clinically suspicious for Goldenhar’s syndrome, consult pediatrician with genetics specialty


SURGERY/OTHER PROCEDURES


• Pap: Excisional biopsy with or without cryotherapy if symptomatic, or if concern for malignancy


• KS: Surgical excision, if refractory to HAART, with 1–2 mm margins


• LD: Superficial sclerokeratectomy with or without lamellar graft


• Sarc: Surgical excision, if symptomatic


• PG: Surgical excision, if symptomatic


ONGOING CARE


FOLLOW-UP RECOMMENDATIONS


• Outpatient care for periodic observation of lesions and surgical excision of benign conjunctival masses


• Inpatient care for systemic management of complicating illness


PROGNOSIS


Highly favorable prognosis


COMPLICATIONS


• Lesions may reoccur after excision


• Secondary to surgical excision, including scaring, infection, bleeding, blindness


• LD: Refractive error; cornea may remain opacified from scar after surgery


• Systemic complications of underlying conditions



REFERENCES


1. Curtis TH, Durairaj VD. Conjunctival Kaposi sarcoma as the initial presentation of human immunodeficiency virus infection. Ophthal Plast Reconstr Surg 2005;21:314–315.


2. Ferry AP. Pyogenic granulomas of the eye and ocular adnexa: A study of 100 cases. Trans Am Ophthalmol Soc 1989;87:327–347.


3. Tseng SH. Conjunctival papilloma. Ophthalmology 2009;116:1013.


4. Shields CL, Shields JA. Tumors of the conjunctiva and cornea. Surv Ophthalmol 2004;49:3–24.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Nov 9, 2016 | Posted by in OPHTHALMOLOGY | Comments Off on Conjunctival Lesions

Full access? Get Clinical Tree

Get Clinical Tree app for offline access